陶氏蛋白在陶氏病变中的分析:人类大脑研究
Juan Lantero-Rodriguez1,2, Elena Camporesi1,2, Laia Montoliu-Gaya1,2
1Department of Psychiatry & Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Molecular neurodegeneration
|July 18, 2024
概括
这项研究揭示了不同类型的陶氏蛋白在不同类型的陶氏蛋白,发现阿尔茨海默病 (AD) 的陶氏酸化和聚合水平明显高于PSP,PiD和CBD等其他类型的陶氏蛋白.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 病理学 病理学 病理学
背景情况:
- 包括阿尔茨海默氏症 (AD) 在内的陶氏症的特征是异常的陶氏蛋白积累.
- 大脑脊髓液 (CSF) 的生物标志物对于阿尔茨海默病是特异性的,但并非所有病 (例如,PSP,PiD,CBD).
- 了解蛋白形差异跨病变对于诊断和治疗至关重要.
研究的目的:
- 开发和应用一个多重检测法,用于量化不同病的蛋白形状.
- 为了比较AD,PSP,PiD,CBD和控制大脑组织中的非化和化陶的形状.
- 为了识别独特的病理特征,区分AD与其他病.
主要方法:
- 开发了一种结合免疫沉和高分辨率质谱的多重检测方法.
- 从尸检确认的病病例 (AD,PSP,PiD,CBD) 和对照组中分析了可溶和不可溶的大脑组织部分.
- 量化异型,非化 (尤其是含有MTBR的) 和23种不同的化.
主要成果:
- 不酸化的形状在各种形病变中有所不同,AD显示MTBR含有聚合物的12-72倍高水平在不溶性分数中.
- 异形分布有所变化:3R在PiD中占主导地位,而4R在CBD和PSP (不溶性分数) 中更为丰富.
- 所有研究的化在AD不溶性分数中都增加了;双倍和三倍化在AD溶性分数中也增加了,与其他病不同.
结论:
- 异常的陶酸化和聚合发生在非AD类陶病中,但在阿尔茨海默氏症中明显明显.
- 开发的多重检测有效地区分了不同类型的蛋白形状在不同类型的病症.
- 独特的酸化和聚合模式,特别是在AD中,突出了潜在的诊断和治疗目标.
相关概念视频
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...


